Reducing vascular events risk in patients with dyslipidaemia: an update for clinicians

2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult – 2009 recommendations

(2011) Jacques Genest et al.   CANADIAN JOURNAL OF CARDIOLOGY

log(TG)/HDL-C is related to both residual cardiometabolic risk and β-cell function loss in type 2 diabetes males

(2011) Michel P Hermans et al.   Cardiovascular Diabetology

Non-HDL-cholesterol as valid surrogate to apolipoprotein B100 measurement in diabetes: Discriminant Ratio and unbiased equivalence

(2011) Michel P Hermans et al.   Cardiovascular Diabetology

Efficacy and Safety of a Novel Oral Inducer of Apolipoprotein A-I Synthesis in Statin-Treated Patients With Stable Coronary Artery Disease

(2011) Stephen J. Nicholls et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Novel HDL-directed pharmacotherapeutic strategies

(2011) Emil M. deGoma et al.   Nature Reviews Cardiology

Estudio REALIST (REsiduAl risk, LIpids and Standard Therapies): Un análisis del Riesgo Residual dependiente del perfil lipídico en el síndrome coronario agudo

(2011) Jesús Millán Núñez-Cortés et al.   Endocrinologia y Nutricion

Contribution of High Plasma Triglycerides and Low High-Density Lipoprotein Cholesterol to Residual Risk of Coronary Heart Disease After Establishment of Low-Density Lipoprotein Cholesterol Control

(2010) Vincent J. Carey et al.   AMERICAN JOURNAL OF CARDIOLOGY

Underappreciated opportunities for low-density lipoprotein management in patients with cardiometabolic residual risk

(2010) Robert S. Rosenson et al.   ATHEROSCLEROSIS

P132 OPTIMAL TYPE 2 DIABETES MANAGEMENT INCLUDING BENCHMARKING AND STANDARD TREATMENT. BASELINE EUROPEAN RESULTS

(2010) M. Hermans et al.   ATHEROSCLEROSIS SUPPLEMENTS

Apolipoprotein C-III and the Metabolic Basis for Hypertriglyceridemia and the Dense Low-Density Lipoprotein Phenotype

(2010) Chunyu Zheng et al.   CIRCULATION

Reducing residual vascular risk in patients with atherogenic dyslipidemia: where do we go from here?

(2010) Michel P Hermans et al.   Clinical Lipidology

Implications of the ACCORD Lipid study: perspective from the Residual Risk Reduction Initiative (R3i)

(2010) J.C. Fruchart et al.   CURRENT MEDICAL RESEARCH AND OPINION

Redefining Normal Low-Density Lipoprotein Cholesterol

(2010) James S. Forrester   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

A First-in-Man, Randomized, Placebo-Controlled Study to Evaluate the Safety and Feasibility of Autologous Delipidated High-Density Lipoprotein Plasma Infusions in Patients With Acute Coronary Syndrome

(2010) Ron Waksman et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis

(2010) Min Jun et al.   LANCET

Combination Lipid Therapy in Type 2 Diabetes

(2010)   NEW ENGLAND JOURNAL OF MEDICINE

Molecular pathways and agents for lowering LDL-cholesterol in addition to statins

(2010) Philippe Costet   PHARMACOLOGY & THERAPEUTICS

Niacin and fibrates in atherogenic dyslipidemia: Pharmacotherapy to reduce cardiovascular risk

(2010) M. John Chapman et al.   PHARMACOLOGY & THERAPEUTICS

The triglyceride/high-density lipoprotein cholesterol ratio predicts all-cause mortality in women with suspected myocardial ischemia

(2009) Vera Bittner et al.   AMERICAN HEART JOURNAL

Usefulness of Triglycerides-to–High-Density Lipoprotein Cholesterol Ratio for Predicting the First Coronary Event in Men

(2009) Alberto Cordero et al.   AMERICAN JOURNAL OF CARDIOLOGY

Metabolism of Very-Low-Density Lipoprotein and Low-Density Lipoprotein Containing Apolipoprotein C-III and Not Other Small Apolipoproteins

(2009) Carlos O. Mendivil et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Management of non-high-density lipoprotein abnormalities

(2009) Robert S. Rosenson   ATHEROSCLEROSIS

Peroxisome proliferator-activated receptor-alpha (PPARα): At the crossroads of obesity, diabetes and cardiovascular disease

(2009) Jean-Charles Fruchart   ATHEROSCLEROSIS

Harmonizing the Metabolic Syndrome

(2009) K.G.M.M. Alberti et al.   CIRCULATION

ApoB versus non-HDL-C: What to do when they disagree

(2009) Allan Sniderman et al.   Current Atherosclerosis Reports

Centralized Pan-European survey on the under-treatment of hypercholesterolaemia (CEPHEUS): overall findings from eight countries

(2009) Michel P. Hermans et al.   CURRENT MEDICAL RESEARCH AND OPINION

Erectile dysfunction, microangiopathy and UKPDS risk in type 2 diabetes

(2009) Michel P. Hermans et al.   DIABETES & METABOLISM

Introduction

(2009)   DIABETES CARE

Risk Scores for Prediction of Coronary Heart Disease: An Update

(2009) Peter W.F. Wilson   ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA

Lifestyle Approaches and Dietary Strategies to Lower LDL-Cholesterol and Triglycerides and Raise HDL-Cholesterol

(2009) Heather I. Katcher et al.   ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA

Should triglycerides and the triglycerides to high-density lipoprotein cholesterol ratio be used as surrogates for insulin resistance?

(2009) Su-Jong Kim-Dorner et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Residual microvascular risk in diabetes: unmet needs and future directions

(2009) Paola Fioretto et al.   Nature Reviews Endocrinology

Therapeutic regulation of apoB100 metabolism in insulin resistance in vivo

(2009) Gerald F. Watts et al.   PHARMACOLOGY & THERAPEUTICS

Belgian expert opinion: how to reduce the residual risk in atherogenic dyslipidaemic patients: place of fibrates

(2008) J. Ducobu et al.   ACTA CARDIOLOGICA

The Editor’s Roundtable: Expanded Versus Standard Lipid Panels in Assessing and Managing Cardiovascular Risk

(2008) Destry Sulkes et al.   AMERICAN JOURNAL OF CARDIOLOGY

The Editor's Roundtable: Lipid Management Beyond Statins—Reducing Residual Cardiovascular Risk

(2008) Vincent E. Friedewald et al.   AMERICAN JOURNAL OF CARDIOLOGY

Reducing the Residual Risk of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor Therapy With Combination Therapy

(2008) Tamar S. Polonsky et al.   AMERICAN JOURNAL OF CARDIOLOGY

Usefulness of the Triglyceride–High-Density Lipoprotein Versus the Cholesterol–High-Density Lipoprotein Ratio for Predicting Insulin Resistance and Cardiometabolic Risk (from the Framingham Offspring Cohort)

(2008) William B. Kannel et al.   AMERICAN JOURNAL OF CARDIOLOGY

Expert Perspective: Reducing Cardiovascular Risk in Metabolic Syndrome and Type 2 Diabetes Mellitus Beyond Low-Density Lipoprotein Cholesterol Lowering

(2008) Peter H. Jones   AMERICAN JOURNAL OF CARDIOLOGY

The Residual Risk Reduction Initiative: A Call to Action to Reduce Residual Vascular Risk in Patients with Dyslipidemia

(2008) Jean-Charles Fruchart et al.   AMERICAN JOURNAL OF CARDIOLOGY

Comparison of Serum Lipid Values in Subjects With and Without the Metabolic Syndrome

(2008) Alberto Cordero et al.   AMERICAN JOURNAL OF CARDIOLOGY

Overproduction of Very Low–Density Lipoproteins Is the Hallmark of the Dyslipidemia in the Metabolic Syndrome

(2008) Martin Adiels et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Diabetes Patients Requiring Glucose-Lowering Therapy and Nondiabetics With a Prior Myocardial Infarction Carry the Same Cardiovascular Risk

(2008) Tina Ken Schramm et al.   CIRCULATION

The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patients

(2008) Jean-Charles Fruchart et al.   Diabetes & Vascular Disease Research

Cardiovascular risk assessment in the metabolic syndrome: results from the Prospective Cardiovascular Munster (PROCAM) Study

(2008) G Assmann et al.   INTERNATIONAL JOURNAL OF OBESITY

Clinical Significance of High-Density Lipoprotein Cholesterol in Patients With Low Low-Density Lipoprotein Cholesterol

(2008) Emil M. deGoma et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Statin Therapy Alters the Relationship Between Apolipoprotein B and Low-Density Lipoprotein Cholesterol and Non–High-Density Lipoprotein Cholesterol Targets in High-Risk Patients

(2008) Christie M. Ballantyne et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Lipoprotein Management in Patients With Cardiometabolic Risk

(2008) John D. Brunzell et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies

(2008) Theodore Mazzone et al.   LANCET

Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes

(2008) Peter Gæde et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

(2008) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dietary carbohydrate restriction induces a unique metabolic state positively affecting atherogenic dyslipidemia, fatty acid partitioning, and metabolic syndrome

(2008) Jeff S. Volek et al.   PROGRESS IN LIPID RESEARCH